MRI (Magnetic Resonance Imaging) is particularly useful for assessing the nasopharynx, surrounding soft tissues, and skull base.
It can help identify:
-
The primary tumor.
-
Extension into nearby structures.
-
Involvement of the skull base.
-
Abnormal lymph nodes in the neck.
-
Possible involvement of nerves or other surrounding tissues.
CT (Computed Tomography) may also be used to examine the head, neck, chest, or other areas when appropriate.
CT imaging provides detailed information about bone structures and can help assess certain patterns of disease spread.
The choice of imaging depends on the patient's clinical situation and the specialist's assessment.
5. EBV DNA Testing
Plasma Epstein-Barr virus DNA testing is an important tool in the management of nasopharyngeal carcinoma.
It measures the amount of EBV DNA circulating in the blood.
In many patients with NPC, circulating EBV DNA can be detected and may reflect tumor activity.
Doctors may use this test to:
-
Support risk assessment in selected high-risk populations.
-
Assist with evaluating suspected disease.
-
Help assess treatment response.
-
Monitor patients after treatment.
-
Identify possible recurrence when interpreted alongside other findings.
However, EBV DNA testing is not a standalone diagnostic test.
A negative result does not exclude every case of NPC, and a positive result does not automatically confirm cancer.
6. PET-CT and Other Tests for Staging
If nasopharyngeal cancer is confirmed, doctors may recommend additional investigations to determine whether the disease has spread.
A PET-CT scan can help identify areas of increased metabolic activity throughout the body.
Depending on the clinical situation, doctors may also request:
-
Chest imaging.
-
Blood tests to assess general health.
-
Additional MRI or CT scans.
-
Evaluation of suspicious lymph nodes.
-
Other investigations guided by symptoms and examination findings.
These tests help establish the cancer stage and guide treatment planning.
6. How Is Nasopharyngeal Cancer Treated?
Treatment depends on the stage of the disease, tumor characteristics, lymph node involvement, the patient's general health, and other clinical factors.
Unlike many tumors in other parts of the body, nasopharyngeal cancer is often treated primarily with radiation therapy because of its location near important structures.
1. Radiotherapy
Radiotherapy is a major treatment for nasopharyngeal cancer.
It uses high-energy radiation to damage the DNA of cancer cells, preventing them from growing and dividing.
Modern treatment commonly uses intensity-modulated radiation therapy (IMRT), which allows doctors to shape radiation doses more precisely around the tumor while reducing exposure to nearby healthy tissues.
Radiotherapy may be used alone for selected early-stage cases or combined with chemotherapy for more advanced disease.
Possible side effects include:
-
Dry mouth.
-
Sore throat.
-
Difficulty swallowing.
-
Changes in taste.
-
Skin irritation.
-
Fatigue.
-
Hearing changes.
-
Dental complications.
Many side effects improve after treatment, although some may persist and require long-term supportive care.
2. Chemotherapy
Chemotherapy uses medication to destroy cancer cells or prevent them from multiplying.
For many patients with locally advanced nasopharyngeal cancer, chemotherapy is combined with radiotherapy to improve treatment effectiveness.
Depending on the disease stage and treatment plan, chemotherapy may be administered:
-
Before radiotherapy (induction chemotherapy).
-
At the same time as radiotherapy (concurrent chemoradiotherapy).
-
After initial treatment in selected situations.
Common chemotherapy medicines include platinum-based drugs such as cisplatin.
Side effects vary according to the medication and dosage and may include nausea, fatigue, reduced blood cell counts, hearing impairment, and kidney-related complications.
Patients should be monitored carefully throughout treatment.
3. Immunotherapy and Targeted Treatment
For certain patients with recurrent or metastatic nasopharyngeal cancer, immunotherapy may be an important treatment option.
Immune checkpoint inhibitors, including drugs targeting the PD-1 pathway, help the immune system recognize and attack cancer cells.
Some patients may also receive chemotherapy in combination with immunotherapy, depending on the clinical setting and available treatment guidelines.
Targeted treatments and other systemic therapies may be considered in selected situations.
These treatments are not suitable for everyone, and their use depends on disease characteristics, previous treatment, and individual medical circumstances.
4. Surgery
Surgery is not usually the primary treatment for the original nasopharyngeal tumor because of its location and proximity to important structures.
However, surgical procedures may have a role in selected cases.
For example, surgery may be considered for certain persistent or recurrent lymph nodes in the neck or for carefully selected local recurrences.
Treatment decisions should be made by a multidisciplinary team with experience in head and neck cancer.
7. How Can You Reduce Your Risk of Nasopharyngeal Cancer?
There is no guaranteed way to prevent nasopharyngeal cancer.
Some risk factors, including inherited genetic susceptibility and EBV infection, cannot be completely avoided.
However, several practical measures may help reduce exposure to known or suspected risk factors.
1. Choose Fresh Foods More Frequently
Try to make fresh fruits, vegetables, and minimally processed foods the foundation of your daily diet.
Reduce frequent consumption of heavily salted and preserved foods, particularly traditional preserved fish products associated with NPC risk.
Include a variety of:
-
Leafy green vegetables.
-
Fresh citrus fruits.
-
Tomatoes.
-
Broccoli and other cruciferous vegetables.
-
Whole grains.
-
Beans and lentils.